Arcus Biosciences (RCUS) Cash from Investing Activities Growth (3y) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 116.52% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 38.24% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -22.09% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 30.54% |
| 10 | Arcus Biosciences | 3.18 Bn | 2.36 Bn | - | -4.04% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.04% |
| Dec 31, 2025 | -80.41% |
| Sep 30, 2025 | 50.88% |
| Jun 30, 2025 | 38.16% |
| Mar 31, 2025 | 28.45% |
| Dec 31, 2024 | 39.51% |
| Sep 30, 2024 | 31.09% |
| Jun 30, 2024 | 175.80% |
| Mar 31, 2024 | -67.39% |
| Dec 31, 2023 | 490.48% |
| Sep 30, 2023 | 26.59% |
| Jun 30, 2023 | 31.97% |
| Mar 31, 2023 | 47.68% |
| Dec 31, 2022 | 80.52% |
| Sep 30, 2022 | -8.84% |
| Jun 30, 2022 | -115.88% |
| Mar 31, 2022 | -174.88% |
| Dec 31, 2021 | 95.57% |
| Sep 30, 2021 | -2.07% |
| Jun 30, 2021 | 29.79% |
| Mar 31, 2021 | 79.77% |
| Dec 31, 2020 | 26.06% |
| Sep 30, 2020 | -218.82% |
| Jun 30, 2020 | -199.44% |
| Mar 31, 2020 | 64.22% |